Cardiac resynchronization therapy for patients with mild to moderately reduced ejection fraction and left bundle...

Area of Science:

• Cardiology
• Electrophysiology
• Heart Failure Management

Background:

• The efficacy of cardiac resynchronization therapy (CRT) in patients with mild to moderately reduced ejection fraction (HFmmrEF) and left bundle branch block (LBBB) remains uncertain.
• Investigating CRT's impact on HF progression in this specific patient demographic is crucial.

Purpose of the Study:

• To evaluate the outcomes of CRT in patients diagnosed with HFmmrEF and left ventricular conduction delay.
• To determine if CRT improves cardiac function and reduces ventricular remodeling.

Main Methods:

• A prospective, randomized clinical trial involving 76 patients with LVEF between 36%-50% and LBBB.
• Patients were randomized to CRT-OFF or CRT-ON, with programming switched at 6 months.
• Primary endpoint was change in left ventricular end-systolic volume (LVESV); secondary endpoints included LVEF, New York Heart Association class, and N-terminal pro-brain natriuretic peptide levels.

Main Results:

• CRT significantly reduced LVESV and improved LVEF in patients with HFmmrEF and LBBB.
• Patients receiving CRT-ON demonstrated significant reductions in LVESV and improvements in LVEF compared to baseline.
• The study observed significant improvements in LVEF and ventricular remodeling after 6 months of CRT.

Conclusions:

• Cardiac resynchronization therapy (CRT) significantly enhances left ventricular ejection fraction (LVEF) and promotes ventricular remodeling in patients with HFmmrEF and LBBB.
• This study provides novel evidence supporting the early application of CRT for beneficial outcomes in patients with HFmmrEF and LBBB.